Summary
- Profile Type
- Business request
- POD Reference
- BRRO20250617014
- Term of Validity
- 23 June 2025 - 23 June 2026
- Company's Country
- Romania
- Type of partnership
- Commercial agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A Romanian startup developing an AI-powered digital therapeutic platform for psychosis detection and auditory hallucination management seeks international R&D partners to support certification as a Class IIb medical device and codevelop novel use cases in defense, trauma care, and space applications.
- Full Description
-
GOBLIN AI SRL is a Romanian startup founded in 2023, focused on delivering intelligent digital health solutions targeting mental health challenges in extreme or isolated environments. Its flagship innovation, the GOBLIN platform, combines eye-tracking, large language models (LLMs), and Avatar Therapy principles to detect and manage auditory hallucinations and psychotic episodes in real-time.
The company now seeks international research and development partners for two main objectives:
1. To support GOBLIN’s path to CE certification as a Class IIb medical device under the EU Medical Device Regulation (MDR), focusing on risk classification, clinical evidence collection, usability testing, and documentation for regulatory
approval.
2. To co-develop new use cases for GOBLIN’s modular and AI-based architecture in critical environments such as:
- Military and defense applications (PTSD, isolation-induced psychosis)
- Space medicine (astronaut psychological support in long-duration missions)
- Maritime or polar missions (remote resilience interventions)
- Emergency trauma therapy (acute psychosis and hallucination mitigation)
- Digital biomarkers for neuropsychiatric diagnostics
The partners will collaborate with GOBLIN AI on use-case validation, clinical scenario testing, and will be invited to join
future Horizon Europe and ESA-aligned consortia. - Advantages and Innovations
-
- Combines multiple AI technologies: eye-tracking, LLMs, and digital avatars
- Addresses early detection and real-time mitigation of psychosis symptoms
- Designed for use in inaccessible or high-stress environments (space, defense, maritime)
- Modular system for remote updates and integration with biometric wearables
- Supports non-invasive, autonomous interventions outside traditional healthcare facilities
- Readiness to evolve into a Class IIb CE-certified digital therapeutic - Technical Specification or Expertise Sought
-
We are looking for partners with expertise in any of the following:
- Medical device certification under MDR, especially for Class IIb devices
- Digital mental health interventions, e.g., AVATAR Therapy, CBTp, EMDR
- Clinical trials and usability studies involving AI-based tools
- Human factors engineering, user interaction in neurodigital interfaces
- Space medicine, defense mental health, or trauma care innovation
- Regulatory science and digital biomarker validation
- Semantic AI or AI model alignment for patient safety in LLMs
The ideal partner should be able to co-develop validation protocols, contribute to technical documentation for CE/MDR, and explore integration with existing clinical or operational workflows. - Stage of Development
- Lab tested
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- Goal 9: Industry, Innovation and Infrastructure
- Goal 16: Peace and Justice Strong Institutions
- IPR status
- IPR applied but not yet granted
Partner Sought
- Expected Role of a Partner
-
- Identification and piloting of novel use cases
- Joint development of testbeds for resilience, psychotrauma, or remote behavioral health
- Potential participation in EU-funded research proposals - Type and Size of Partner
- SME 50 - 249
- University
- R&D Institution
- SME 11-49
- SME <=10
- Type of partnership
- Commercial agreement
Dissemination
- Technology keywords
- 06001014 - Neurology, Brain Research
- 01003022 - Smart Appliances
- 01003003 - Artificial Intelligence (AI)
- 06001005 - Diagnostics, Diagnosis
- 01003018 - User Interfaces, Usability
- Market keywords
- 05003006 - Other therapeutic (including defibrillators)
- 05001007 - Other diagnostic
- 05006 - Anatomy, Pathology, Immunology, Physiology
- 05005022 - Other clinical medicine
- 05007007 - Other medical/health related (not elsewhere classified)
- Targeted countries
- All countries